Can-Fite Of Israel To Shift Production Operations To China To Lower Costs
This article was originally published in PharmAsia News
Executive Summary
Israel's Can-Fite BioPharma said it plans to move its production operations to China to take advantage of lower costs it achieved by partnering with Chemspec in making active pharmaceutical ingredients.